Attached files
| file | filename |
|---|---|
| S-1MEF - FORM S-1MEF - PDS Biotechnology Corp | s000911x10_s1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Edge Therapeutics, Inc.:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
September 30, 2015